P53 could be key to therapies for salivary gland cancer
Mouse models show that activating a non-mutated form of the gene could lead to developing therapies for salivary gland cancer.
List view / Grid view
Mouse models show that activating a non-mutated form of the gene could lead to developing therapies for salivary gland cancer.
Using cyro-electron microscopy, researchers have imaged the binding site between a molecule and the tumour suppressor protein PP2A, enabling optimisation of the drug compound.
Tumours with alterations in the CDK12 gene were more responsive to immunotherapy, suggesting precision medicine approach...
Researchers have discovered the process that allows immune suppressor cells to develop, suggesting a potential new way to bolster immunotherapy treatment...